522 related articles for article (PubMed ID: 16858009)
1. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
Turner NA; O'Regan DJ; Ball SG; Porter KE
FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
[TBL] [Abstract][Full Text] [Related]
4. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1747-56. PubMed ID: 17379756
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
6. RhoA prenylation inhibitor produces relaxation of tonic smooth muscle of internal anal sphincter.
Patel CA; Rattan S
J Pharmacol Exp Ther; 2007 May; 321(2):501-8. PubMed ID: 17322025
[TBL] [Abstract][Full Text] [Related]
7. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells.
Shimizu S; Tahara M; Ogata S; Hashimoto K; Morishige K; Tasaka K; Murata Y
Mol Hum Reprod; 2007 Mar; 13(3):181-7. PubMed ID: 17227815
[TBL] [Abstract][Full Text] [Related]
8. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
9. The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle.
Schaafsma D; Dueck G; Ghavami S; Kroeker A; Mutawe MM; Hauff K; Xu FY; McNeill KD; Unruh H; Hatch GM; Halayko AJ
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):394-403. PubMed ID: 20463291
[TBL] [Abstract][Full Text] [Related]
10. RhoA/rho-associated kinase mediates fibroblast contractile force generation.
Yee HF; Melton AC; Tran BN
Biochem Biophys Res Commun; 2001 Feb; 280(5):1340-5. PubMed ID: 11162676
[TBL] [Abstract][Full Text] [Related]
11. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
[TBL] [Abstract][Full Text] [Related]
12. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
Blanco-Colio LM; Muñoz-García B; Martín-Ventura JL; Lorz C; Díaz C; Hernández G; Egido J
Circulation; 2003 Sep; 108(12):1506-13. PubMed ID: 12952848
[TBL] [Abstract][Full Text] [Related]
13. Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi.
Cazzola M; Calzetta L; Page CP; Rinaldi B; Capuano A; Matera MG
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):704-10. PubMed ID: 21278325
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
[TBL] [Abstract][Full Text] [Related]
15. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation.
Wong B; Lumma WC; Smith AM; Sisko JT; Wright SD; Cai TQ
J Leukoc Biol; 2001 Jun; 69(6):959-62. PubMed ID: 11404382
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA.
Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB
Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts.
Carlin CM; Peacock AJ; Welsh DJ
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):447-56. PubMed ID: 17556673
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
Zhu Y; Casey PJ; Kumar AP; Pervaiz S
Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
